Return On Equity in % of Alzamend Neuro, Inc. from 2021 to Q1 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Alzamend Neuro, Inc. quarterly/annual Return On Equity history and growth rate from 2021 to Q1 2025.
  • Alzamend Neuro, Inc. Return On Equity for the quarter ending April 30, 2025 was -181 %, a 144% decline year-over-year.
  • Alzamend Neuro, Inc. annual Return On Equity for 2024 was 187 %.
  • Alzamend Neuro, Inc. annual Return On Equity for 2023 was -138 %, a 24.3% decline from 2022.
  • Alzamend Neuro, Inc. annual Return On Equity for 2022 was -111 %, a 99.8% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

Alzamend Neuro, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 -181 -594 -144% Feb 1, 2025 Apr 30, 2025
Q4 2024 -504 -1.74K -141% Nov 1, 2024 Jan 31, 2025
Q3 2024 547 +1.54K Aug 1, 2024 Oct 31, 2024
Q2 2024 275 +625 May 1, 2024 Jul 31, 2024
Q1 2024 412 Feb 1, 2024 Apr 30, 2024
Q4 2023 1.24K Nov 1, 2023 Jan 31, 2024
Q3 2023 -993 Aug 1, 2023 Oct 31, 2023
Q2 2023 -350 May 1, 2023 Jul 31, 2023

Alzamend Neuro, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 187 May 1, 2024 Apr 30, 2025
2023 -138 -27 -24.3% May 1, 2023 Apr 30, 2024
2022 -111 +64.9K +99.8% May 1, 2022 Apr 30, 2023
2021 -65K May 1, 2021 Apr 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.